Please login to the form below

Not currently logged in
Email:
Password:

research costs

This page shows the latest research costs news and features for those working in and with pharma, biotech and healthcare.

Avenir acquires Cherry, EY wins new account and GK unites businesses

Avenir acquires Cherry, EY wins new account and GK unites businesses

The tech could potentially improve patient outcomes, reduce healthcare costs and accelerate medical research, and the new agreement with EY will allow Sensyne to further scale up its business, including responding ... Unlocking the power within

Latest news

  • NHS England pledges to streamline clinical trial setup NHS England pledges to streamline clinical trial setup

    The process will also target the procedure for reimbursements in additional treatment costs. ... The new processes will also try to simplify and speed up the process for reimbursements for excess treatment costs in non-commercial research, says NHS

  • Profit: the ugly, dirty truth? Profit: the ugly, dirty truth?

    The absence of a sustainable market-place to mitigate risk in research and development costs explains why so many global players have left the field. ... It’s not a recipe for delivering the vast investment into antibiotics research that is needed.

  • Is agile working benefiting the employee or the organisation? Is agile working benefiting the employee or the organisation?

    Beyond the obvious business benefit of reduced office costs, research also tells us agile working improves morale, increases staff retention and importantly widens and unlocks a bigger talent pool, wherein a ... Our experience of developing flexible

  • Biologics set to revolutionise the gastrointestinal market Biologics set to revolutionise the gastrointestinal market

    That's according to GBI Research, which predicts an annual growth rate of 4.45% for the therapy area and expects Takeda to take over as market leader from AbbVie by ... biologics. Jennifer Goossens, associate analyst for GBI Research, said: “Due to the

  • BMS to explore new options for its immuno-oncology drug Opdivo BMS to explore new options for its immuno-oncology drug Opdivo

    BMS has agreed to an upfront payment of $10m to PsiOxus, with both companies sharing subsequent research costs. ... Research from the CheckMate-141 trial halted earlier this year revealed PD-1 immune checkpoint inhibitor Opdivo boosted survival rates in

More from news
Approximately 0 fully matching, plus 47 partially matching documents found.

Latest Intelligence

  • Cost containment and the German market Cost containment and the German market

    The country provides a growing healthcare market for manufacturers, with a good infrastructure, qualified employees and a number of research institutions enabling a productive knowledge exchange. ... Innovative medicine requires high research and

  • Applying real-world evidence to orphan drugs Applying real-world evidence to orphan drugs

    However, for many rare disease therapies, the research and development (R&D) costs far outweigh the expected revenue once the product is launched. ... In Europe, the EU Committee of Experts on Rare Diseases (EUCERD) and the European Platform for Rare

  • The Maverick: giving medicines away free The Maverick: giving medicines away free

    Why patent it, when it won't work on anyone else?”. He says this model also cuts down on research and development costs, which he claims could be reduced to just ... This would also drastically reduce manufacturing costs. He also wants other

  • The importance of real-world data to the pharma industry The importance of real-world data to the pharma industry

    The past decade has seen global commercial clinical trial activity decline significantly due to slow start-up times, low patient recruitment, and high and variable costs. ... Increasingly RWD can ensure continuing research activities; the need for data

  • Case study: Overcoming resistance Case study: Overcoming resistance

    Post-campaign consumer research showed the campaign reached 29 per cent of the population and generated a positive shift in behaviour. ... That increases pressure and costs for the NHS. . Additionally, research shows that people are not aware of the

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

  • Is agile working benefiting the employee or the organisation?

    Beyond reduced office costs, research tells us that agile working improves morale, increases staff retention and importantly widens and unlocks a bigger talent pool.  . ... In this blog Angela draws on her experience and reflects on how the development

  • AskMED.co.uk

    AskMED brings medical professionals together online to provide rapid analysis and feedback for industry questions at a fraction of traditional research costs.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...
What is changing in mental health and dementia care?
Paul Midgley, of Wilmington Healthcare, takes a look at the NHS Long Term Plan's bid to transform mental health and dementia services...

Infographics